Hypofractionated radiotherapy for localized prostate cancer: From phase III evidence to real-world outcomes with or without elective pelvic nodal irradiation.
PURPOSE Hypofractionated radiotherapy is a standard treatment for localized prostate cancer, supported by phase III trials showing non-inferiority versus conventional fractionation. However, most trials excluded elective pelvic lymph node irradiation, so evidence remains limited when pelvic nodes are treated. The prima...